Acrylic dispersion-based coating compositions

Information

  • Patent Grant
  • 10053597
  • Patent Number
    10,053,597
  • Date Filed
    Wednesday, January 8, 2014
    10 years ago
  • Date Issued
    Tuesday, August 21, 2018
    5 years ago
Abstract
Coating compositions and methods for their preparation are described. The coating compositions can include a first copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The first copolymer can have a Tg from −50° C. to −23° C. and is present in an amount of 10-50% by weight based on the total polymer content. The coating compositions can also include a second copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The second copolymer can have a Tg from −15° C. to 25° C. and is present in an amount of 50-90% by weight based on the total polymer content. Further described herein are dried coatings, methods for coating a substrate, and methods for producing a coating.
Description
BACKGROUND

Desirable properties for coating compositions suitable for use in roofing applications are set, for example, by the American Society for Testing Materials (ASTM). ASTM D 6083-05 specifies that desirable properties of roof coatings include high tensile strength, high elongation, high flexibility, and mandrel bend performance at low temperatures. At the present time, roof coatings that meet these performance properties are typically based on polyurethane, silicone or polyvinyl chloride (PVC) polymers or copolymers. However, these coatings are often solvent borne and expensive. Thus, there is a need in the art to provide coating compositions that are able to achieve and even exceed the desired performance properties set forth in ASTM D 6083-05 at a cost effective level.


SUMMARY

Coating compositions and methods for their preparation are described. The coating compositions comprise a first copolymer and a second copolymer. In some embodiments, the coating compositions can include a first copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The first copolymer can have a Tg from −50° C. to −23° C. and is present in an amount of 10-50% by weight based on the total polymer content. The coating compositions also include a second copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The second copolymer can have a Tg from −15° C. to 25° C. and is present in an amount of 50-90% by weight based on the total polymer content. The coating compositions can further include a filler comprising at least one pigment, a pigment dispersing agent, a thickener, a defoamer, a surfactant, and water. The coating composition can have a viscosity of from 12,000 to 85,000 cps at 25° C., a volume solids of greater than 50%, and a weight solids of greater than 60%. Also, the coating composition, when applied as a film, dried and weathered for 1000 hours, can pass the mandrel bend test set forth in ASTM D 6083-05 at at −26° C. and can optionally have a tensile strength of greater than 300 psi.


The at least one first copolymer can be present in an amount of 20-30% by weight based on the total polymer content. In some examples, the first copolymer has a Tg of from −36° C. to −23° C. The second copolymer can have a Tg of from −12° C. to 0° C. In some examples, at least one of the first copolymer and the second copolymer is a styrene acrylic copolymer. In some examples, the first copolymer and the second copolymer are pure acrylics. The first copolymer and the second copolymer can each be derived from at least one low Tg monomer selected from the group consisting of butyl acrylate and 2-ethylhexyl acrylate. Optionally, at least one of the first copolymer and the second copolymer are further derived from at least one high Tg monomer selected from the group consisting of methyl methacrylate and styrene. At least one of the first copolymer and the second copolymer can be derived from a crosslinkable monomer. The acid monomers in the first copolymer and the second copolymer can each be selected from the group consisting acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and mixtures thereof. At least one of the first copolymer and the second copolymer can be further derived from (meth)acrylamide.


The coating composition can further include one or more of a biocide, a dispersing agent, and a coalescing agent. In some examples, the coating composition can further include a quick setting additive (e.g., a polyamine such as polyethyleneimine or a derivatized polyamine such as an alkoxylated polyethyleneimine).


In other embodiments, the coating compositions can comprise a composition including a first copolymer and a second copolymer. In these examples, the first copolymer is produced by emulsion polymerization and derived from one or more monomers including one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate. The first copolymer can have a Tg from −36° C. to −23° C. In these examples, the second copolymer is produced by emulsion polymerization and derived from one or more monomers including one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate. The second copolymer can have a Tg from −12° C. to 0° C. The first copolymer and the second copolymer can be dispersed in an aqueous medium.


Also described herein are dried coatings. The dried coatings can be formed by drying a composition as described herein.


Further described herein are methods of coating a substrate. The method can include applying a coating composition as described herein to a surface. In some examples, the surface is a roof surface. In some examples, the surface is a wall.


Methods of producing a coating are also provided herein. The methods include mixing a composition as described herein with a filler comprising at least one pigment, a dispersing agent, a thickener, a defoamer, and a stabilizer.


The details of one or more embodiments are set forth in the description below. Other features, objects, and advantages will be apparent from the description and from the claims.







DETAILED DESCRIPTION

Acrylic dispersion-based coating compositions and methods of their preparation and use are described herein. The coating compositions include a first copolymer and a second copolymer. The first copolymer described herein can be derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The second copolymer described herein can be derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene.


The one or more (meth)acrylates can include esters of α,β-monoethylenically unsaturated mono- and dicarboxylic acids having 3 to 6 carbon atoms with alkanols having 1 to 12 carbon atoms (e.g., esters of acrylic acid, methacrylic acid, maleic acid, fumaric acid, or itaconic acid, with C1-C12, C1-C8, or C1-C4 alkanols). In some examples, the one or more (meth)acrylates for preparing the first copolymer and/or second copolymer are selected from butyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, and mixtures of these.


The one or more acid monomers can include α,β-monoethylenically unsaturated mono- and dicarboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, crotonic acid, dimethacrylic acid, ethylacrylic acid, allylacetic acid, vinylacetic acid, mesaconic acid, methylenemalonic acid, or citraconic acid). In some examples, the one or more acid monomers for preparing the first copolymer and/or second copolymer are selected from the group consisting acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and mixtures of these.


Optionally, the first copolymer and the second copolymer are each derived from at least one low glass transition temperature (Tg) monomer. As used herein, a low Tg monomer refers to a monomer having a Tg value of less than −40° C. for the corresponding homopolymer. Examples of suitable low Tg monomers include butyl acrylate (Tg value of −43° C.) and 2-ethylhexyl acrylate (Tg value of −58° C.).


Optionally, the first copolymer and the second copolymer are each derived from at least one high Tg monomer. As used herein, a high Tg monomer refers to a monomer having a Tg value of greater than 40° C. for the corresponding homopolymer. Examples of suitable high Tg monomers include methyl methacrylate (Tg value of 105° C.) and styrene (Tg value of 100° C.).


In some embodiments, at least one of the first copolymer and the second copolymer is further derived from an acrylamides or an alkyl-substituted acrylamide. Suitable examples include N-tert-butylacrylamide and N-methyl(meth)acrylamide. In some embodiments, at least one of the first copolymer and the second copolymer is further derived from (meth)acrylamide.


Optionally, at least one of the first copolymer and the second copolymer is derived from a crosslinkable monomer. For example, the crosslinkable monomer can include diacetone acrylamide (DAAM) or a self-crosslinking monomer such as a monomer comprising 1,3-diketo groups (e.g., acetoacetoxyethyl(meth)acrylate) or a silane crosslinker. Examples of suitable silane crosslinkers include 3-methacryloxypropyl trimethoxysilane, 3-mercaptopropyl trimethoxysilane, vinyltriethoxysilane, and polyvinyl-siloxane oligomers such as DYNASYLAN 6490, a polyvinyl siloxane oligomer derived from vinyltrimethoxysilane, and DYNASYLAN 6498, a polyvinyl siloxane oligomer derived from vinyltriethoxysilane, both commercially available from Evonik Degussa GmbH (Essen, Germany) The polyvinyl siloxane oligomer can have the following structure:




embedded image



wherein n is an integer from 1 to 50 (e.g., 10). Crosslinkable monomers as described herein can further include monomers such as divinylbenzene; 1,4-butanediol diacrylate; methacrylic acid anhydride; and monomers containing urea groups (e.g., ureidoethyl(meth)acrylate, acrylamidoglycolic acid, and methacrylamidoglycolate methyl ether. Additional examples of crosslinkable monomers include N-alkylolamides of α,β-monoethylenically unsaturated carboxylic acids having 3 to 10 carbon atoms and esters thereof with alcohols having 1 to 4 carbon atoms (e.g., N-methylolacrylamide and N-methylolmethacrylamide); glyoxal based crosslinkers; monomers containing two vinyl radicals; monomers containing two vinylidene radicals; and monomers containing two alkenyl radicals. Exemplary crosslinkable monomers include diesters or triesters of dihydric and trihydric alcohols with α,β-monoethylenically unsaturated monocarboxylic acids (e.g., di(meth)acrylates, tri(meth)acrylates), of which in turn acrylic acid and methacrylic acid can be employed. Examples of such monomers containing two non-conjugated ethylenically unsaturated double bonds are alkylene glycol diacrylates and dimethacrylates, such as ethylene glycol diacrylate, 1,3-butylene glycol diacrylate, 1,4-butylene glycol diacrylate and propylene glycol diacrylate, vinyl methacrylate, vinyl acrylate, allyl methacrylate, allyl acrylate, diallyl maleate, diallyl fumarate and methylenebisacrylamide. In some examples, the first copolymer and/or the second copolymer can include from 0 to 5% by weight of one or more crosslinkable monomers.


The first copolymer and/or second copolymer can further include additional monomers. Further examples of additional monomers include vinylaromatics such as α- and p-methylstyrene, α-butylstyrene, 4-n-butylstyrene, 4-n-decylstyrene, and vinyltoluene; conjugated dienes (e.g., isoprene); anhydrides of α,β-monoethylenically unsaturated mono- and dicarboxylic acids (e.g., maleic anhydride, itaconic anhydride, and methylmalonic anhydride); (meth)acrylonitrile; vinyl and vinylidene halides (e.g., vinyl chloride and vinylidene chloride); vinyl esters of C1-C18 mono- or dicarboxylic acids (e.g., vinyl acetate, vinyl propionate, vinyl n-butyrate, vinyl laurate and vinyl stearate); C1-C4 hydroxyalkyl esters of C3-C6 mono- or dicarboxylic acids, especially of acrylic acid, methacrylic acid or maleic acid, or their derivatives alkoxylated with from 2 to 50 moles of ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, or esters of these acids with C1-C18 alcohols alkoxylated with from 2 to 50 mol of ethylene oxide, propylene oxide, butylene oxide or mixtures thereof (e.g., hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, and methylpolyglycol acrylate); and monomers containing glycidyl groups (e.g., glycidyl methacrylate).


Further examples of additional monomers or co-monomers that can be used include linear 1-olefins, branched-chain 1-olefins or cyclic olefins (e.g., ethene, propene, butene, isobutene, pentene, cyclopentene, hexene, and cyclohexene); vinyl and allyl alkyl ethers having 1 to 40 carbon atoms in the alkyl radical, wherein the alkyl radical can possibly carry further substituents such as a hydroxyl group, an amino or dialkylamino group, or one or more alkoxylated groups (e.g., methyl vinyl ether, ethyl vinyl ether, propyl vinyl ether, isobutyl vinyl ether, 2-ethylhexyl vinyl ether, vinyl cyclohexyl ether, vinyl 4-hydroxybutyl ether, decyl vinyl ether, dodecyl vinyl ether, octadecyl vinyl ether, 2-(diethylamino)ethyl vinyl ether, 2-(di-n-butylamino)ethyl vinyl ether, methyldiglycol vinyl ether, and the corresponding allyl ethers); sulfo-functional monomers (e.g., allylsulfonic acid, methallylsulfonic acid, styrenesulfonate, vinylsulfonic acid, allyloxybenzenesulfonic acid, 2-acrylamido-2-methylpropanesulfonic acid, and their corresponding alkali metal or ammonium salts, sulfopropyl acrylate and sulfopropyl methacrylate); phosphorus-containing monomers (e.g., dihydrogen phosphate esters of alcohols in which the alcohol contains a polymerizable vinyl or olefenic group, allyl phosphate, phosphoalkyl(meth)acrylates such as 2-phosphoethyl(meth)acrylate (PEM), 2-phosphopropyl(meth)acrylate, 3-phosphopropyl(meth)acrylate, and phosphobutyl(meth)acrylate, 3-phospho-2-hydroxypropyl(meth)acrylate, mono- or di-phosphates of bis(hydroxymethyl) fumarate or itaconate; phosphates of hydroxyalkyl(meth)acrylate, 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, ethylene oxide condensates of (meth)acrylates, H2C═C(CH3)COO(CH2CH2O)nP(O)(OH)2, and analogous propylene and butylene oxide condensates, where n is an amount of 1 to 50, phosphoalkyl crotonates, phosphoalkyl maleates, phosphoalkyl fumarates, phosphodialkyl(meth)acrylates, phosphodialkyl crotonates, vinyl phosphonic acid, allyl phosphonic acid, 2-acrylamido-2methylpropanephosphinic acid, α-phosphonostyrene, 2-methylacrylamido-2-methylpropanephosphinic acid, (hydroxy)phosphinylalkyl(meth)acrylates, (hydroxy)phosphinylmethyl methacrylate, and combinations thereof); alkylaminoalkyl(meth)acrylates or alkylaminoalkyl(meth)acrylamides or quaternization products thereof (e.g., 2-(N,N-dimethylamino)ethyl(meth)acrylate, 3-(N,N-dimethylamino)propyl(meth)acrylate, 2-(N,N,N-trimethylammonium)ethyl(meth)acrylate chloride, 2-dimethylaminoethyl(meth)acrylamide, 3-dimethylaminopropyl(meth)acrylamide, and 3-trimethylammoniumpropyl(meth)acrylamide chloride); allyl esters of C1-C30 monocarboxylic acids; N-vinyl compounds (e.g., N-vinylformamide, N-vinyl-N-methylformamide, N-vinylpyrrolidone, N-vinylimidazole, 1-vinyl-2-methylimidazole, 1-vinyl-2-methylimidazoline, N-vinylcaprolactam, vinylcarbazole, 2-vinylpyridine, and 4-vinylpyridine).


The first copolymer and the second copolymer can independently be pure acrylics, styrene acrylics, or vinyl acrylics. In some embodiments, the first copolymer is a styrene acrylic copolymer (i.e., the first copolymer is a styrene acrylic copolymer, the second copolymer is a styrene acrylic copolymer, or both the first copolymer and the second copolymer are styrene acrylic copolymers). In other embodiments, at least one of the first copolymer and the second copolymer is a pure acrylic (i.e., the first copolymer is a pure acrylic, the second copolymer is a pure acrylic, or both the first copolymer and second copolymer are pure acrylics).


The first copolymer and the second copolymer can be prepared by polymerizing the monomers using free-radical emulsion polymerization. The monomers for the first copolymer and the second copolymer can be prepared as aqueous dispersions. The emulsion polymerization temperature is generally from 30° C. to 95° C. or from 75° C. to 90° C. The polymerization medium can include water alone or a mixture of water and water-miscible liquids, such as methanol. In some embodiments, water is used alone. The emulsion polymerization can be carried out either as a batch, semi-batch, or continuous process. Typically, a semi-batch process is used. In some embodiments, a portion of the monomers can be heated to the polymerization temperature and partially polymerized, and the remainder of the polymerization batch can be subsequently fed to the polymerization zone continuously, in steps or with superposition of a concentration gradient.


The free-radical emulsion polymerization can be carried out in the presence of a free-radical polymerization initiator. The free-radical polymerization initiators that can be used in the process are all those which are capable of initiating a free-radical aqueous emulsion polymerization including alkali metal peroxydisulfates and H2O2, or azo compounds. Combined systems can also be used comprising at least one organic reducing agent and at least one peroxide and/or hydroperoxide, e.g., tert-butyl hydroperoxide and the sodium metal salt of hydroxymethanesulfinic acid or hydrogen peroxide and ascorbic acid. Combined systems can also be used additionally containing a small amount of a metal compound which is soluble in the polymerization medium and whose metallic component can exist in more than one oxidation state, e.g., ascorbic acid/iron(II) sulfate/hydrogen peroxide, where ascorbic acid can be replaced by the sodium metal salt of hydroxymethanesulfinic acid, sodium sulfite, sodium hydrogen sulfite or sodium metal bisulfite and hydrogen peroxide can be replaced by tert-butyl hydroperoxide or alkali metal peroxydisulfates and/or ammonium peroxydisulfates. In the combined systems, the carbohydrate derived compound can also be used as the reducing component. In general, the amount of free-radical initiator systems employed can be from 0.1 to 2%, based on the total amount of the monomers to be polymerized. In some embodiments, the initiators are ammonium and/or alkali metal peroxydisulfates (e.g., sodium persulfate), alone or as a constituent of combined systems. The manner in which the free-radical initiator system is added to the polymerization reactor during the free-radical aqueous emulsion polymerization is not critical. It can either all be introduced into the polymerization reactor at the beginning, or added continuously or stepwise as it is consumed during the free-radical aqueous emulsion polymerization. In detail, this depends in a manner known to an average person skilled in the art both from the chemical nature of the initiator system and on the polymerization temperature. In some embodiments, some is introduced at the beginning and the remainder is added to the polymerization zone as it is consumed. It is also possible to carry out the free-radical aqueous emulsion polymerization under superatmospheric or reduced pressure.


The first or second copolymer can each independently be produced by single stage polymerization or multiple stage polymerization. In some embodiments, the first copolymer and the second copolymer are each copolymerized separately to produce a first dispersion including a plurality of polymer particles including the first copolymer and a second dispersion comprising a plurality of polymer particles including the second copolymer. The first and second dispersions can then be combined to provide a dispersion including the first and second copolymers. In some embodiments, the first copolymer and the second copolymer are provided in the same polymer particle by using multiple stage polymerization such that one of the first copolymer and second copolymer can be present as a first stage copolymer (e.g., as a core in a core/shell polymer particle) and one of the first copolymer and second copolymer can be present as a second stage copolymer (e.g., as a shell in a core/shell polymer particle).


One or more surfactants can be included in the aqueous dispersions to improve certain properties of the dispersions, including particle stability. For example, sodium laureth sulfate and alkylbenzene sulfonic acid or sulfonate surfactants could be used. Examples of commercially available surfactants include Calfoam® ES-303, a sodium laureth sulfate, and Calfax® DB-45, a sodium dodecyl diphenyl oxide disulfonate, both available from Pilot Chemical Company (Cincinnati, Ohio). In general, the amount of surfactants employed can be from 0.01 to 5%, based on the total amount of the monomers to be polymerized.


Small amounts (e.g., from 0.01 to 2% by weight based on the total monomer weight) of molecular weight regulators, such as a mercaptan, can optionally be used. Such substances are preferably added to the polymerization zone in a mixture with the monomers to be polymerized and are considered part of the total amount of unsaturated monomers used in the copolymers.


The first copolymer can have a Tg value of less than −20° C. as measured by differential scanning calorimetry (DSC) by measuring the midpoint temperature using ASTM D 3418-08. For example, the Tg of the first copolymer can be from −50° C. to −23° C., −40° C. to −25° C., or −33° C. to −26° C. In some examples, the Tg of the first copolymer is from −36° C. to −23° C. The second copolymer can have a Tg value of greater than −15° C. For example, the Tg of the second copolymer can be from −12° C. to 25° C., −9° C. to 5° C., or −5° C. to 0° C. In some examples, the Tg of the first copolymer is from −12° C. to 0° C.


The first copolymer can be present in the coating composition in an amount of 10-50% by weight based on the total polymer content. For example, the first copolymer can be present in the coating composition in an amount of 15-35% or 20-30% by weight based on the polymer content. The second copolymer can be present in the coating composition in an amount of 50-90% by weight based on the total polymer content. For example, the second copolymer can be present in the coating composition in an amount of 65-85% or 70-80% by weight based on the total polymer content.


In some embodiments, the first copolymer and the second copolymer can be dispersed in an aqueous medium to form an aqueous dispersion. The aqueous dispersion can be used to form the coating composition. The coating composition can further include at least one filler such as a pigment or extender. The term “pigment” as used herein includes compounds that provide color or opacity to the coating composition. Examples of suitable pigments include metal oxides, such as titanium dioxide, zinc oxide, iron oxide, or combinations thereof. The at least one pigment can be selected from the group consisting of TiO2 (in both anastase and rutile forms), clay (aluminum silicate), CaCO3 (in both ground and precipitated forms), aluminum oxide, silicon dioxide, magnesium oxide, talc (magnesium silicate), barytes (barium sulfate), zinc oxide, zinc sulfite, sodium oxide, potassium oxide and mixtures thereof. Examples of commercially titanium dioxide pigments are KRONOS® 2101, KRONOS® 2310, available from Kronos WorldWide, Inc., TI-PURE® R-900, available from DuPont, or TIONA® AT1 commercially available from Millenium Inorganic Chemicals. Titanium dioxide is also available in concentrated dispersion form. An example of a titanium dioxide dispersion is KRONOS® 4311, also available from Kronos WorldWide, Inc. Suitable pigment blends of metal oxides are sold under the marks Minex® (oxides of silicon, aluminum, sodium and potassium commercially available from Unimin Specialty Minerals), Celite® (aluminum oxide and silicon dioxide commercially available from Celite Company), and Atomite® (commercially available from Imerys Performance Minerals). Exemplary fillers also include clays such as attapulgite clays and kaolin clays including those sold under the Attagel® and Ansilex® marks (commercially available from BASF Corporation). Additional fillers include nepheline syenite, (25% nepheline, 55% sodium feldspar, and 20% potassium feldspar), feldspar (an aluminosilicate), diatomaceous earth, calcined diatomaceous earth, talc (hydrated magnesium silicate), aluminosilicates, silica (silicon dioxide), alumina (aluminum oxide), mica (hydrous aluminum potassium silicate), pyrophyllite (aluminum silicate hydroxide), perlite, baryte (barium sulfate), Wollastonite (calcium metasilicate), and combinations thereof. More preferably, the at least one filler includes TiO2, CaCO3, and/or a clay.


Generally, the mean particle sizes of the filler ranges from about 0.01 to about 50 microns. For example, the TiO2 particles used in the aqueous coating composition typically have a mean particle size of from about 0.15 to about 0.40 microns. The filler can be added to the aqueous coating composition as a powder or in slurry form. The filler is preferably present in the aqueous coating composition in an amount from about 5 to about 50 percent by weight, more preferably from about 10 to about 40 percent by weight (i.e. the weight percentage of the filler based on the total weight of the coating composition).


Examples of suitable pigment dispersing agents are polyacid dispersants and hydrophobic copolymer dispersants. Polyacid dispersants are typically polycarboxylic acids, such as polyacrylic acid or polymethacrylic acid, which are partially or completely in the form of their ammonium, alkali metal, alkaline earth metal, ammonium, or lower alkyl quaternary ammonium salts. Hydrophobic copolymer dispersants include copolymers of acrylic acid, methacrylic acid, or maleic acid with hydrophobic monomers. In certain embodiments, the composition includes a polyacrylic acid-type dispersing agent, such as Pigment Disperser N, commercially available from BASF SE.


Examples of suitable thickeners include hydrophobically modified ethylene oxide urethane (HEUR) polymers, hydrophobically modified alkali soluble emulsion (HASE) polymers, hydrophobically modified hydroxyethyl celluloses (HMHECs), hydrophobically modified polyacrylamide, and combinations thereof. HEUR polymers are linear reaction products of diisocyanates with polyethylene oxide end-capped with hydrophobic hydrocarbon groups. HASE polymers are homopolymers of (meth)acrylic acid, or copolymers of (meth)acrylic acid, (meth)acrylate esters, or maleic acid modified with hydrophobic vinyl monomers. HMHECs include hydroxyethyl cellulose modified with hydrophobic alkyl chains. Hydrophobically modified polyacrylamides include copolymers of acrylamide with acrylamide modified with hydrophobic alkyl chains (N-alkyl acrylamide). In certain embodiments, the coating composition includes a hydrophobically modified hydroxyethyl cellulose thickener.


Defoamers serve to minimize frothing during mixing and/or application of the coating composition. Suitable defoamers include organic defoamers such as mineral oils, silicone oils, and silica-based defoamers. Exemplary silicone oils include polysiloxanes, polydimethylsiloxanes, polyether modified polysiloxanes, and combinations thereof. Exemplary defoamers include BYK®-035, available from BYK USA Inc., the TEGO® series of defoamers, available from Evonik Industries, the DREWPLUS® series of defoamers, available from Ashland Inc., and FOAMASTER® NXZ, available from BASF Corporation.


Suitable surfactants include nonionic surfactants and anionic surfactants. Examples of nonionic surfactants are alkylphenoxy polyethoxyethanols having alkyl groups of about 7 to about 18 carbon atoms, and having from about 6 to about 60 oxyethylene units; ethylene oxide derivatives of long chain carboxylic acids; analogous ethylene oxide condensates of long chain alcohols, and combinations thereof. Exemplary anionic surfactants include ammonium, alkali metal, alkaline earth metal, and lower alkyl quaternary ammonium salts of sulfosuccinates, higher fatty alcohol sulfates, aryl sulfonates, alkyl sulfonates, alkylaryl sulfonates, and combinations thereof. In certain embodiments, the composition comprises a nonionic alkylpolyethylene glycol surfactant, such as LUTENSOL® TDA 8 or LUTENSOL® AT-18, commercially available from BASF SE. In certain embodiments, the composition comprises an anionic alkyl ether sulfate surfactant, such as DISPONIL® FES 77, commercially available from BASF SE. In certain embodiments, the composition comprises an anionic diphenyl oxide disulfonate surfactant, such as CALFAX® DB-45, commercially available from Pilot Chemical.


Optionally, the coating compositions can further include quick setting additives. Exemplary quick setting additives suitable for use in the coating compositions described herein includes polyamines (i.e., polymers formed from either an amine-group containing monomer or an imine monomer as polymerized units such as aminoalkyl vinyl ether or sulfides; acrylamide or acrylic esters, such as dimethylaminoethyl(meth)acrylate; N-(meth)acryloxyalkyl-oxazolidines such as poly(oxazolidinylethyl methacrylate), N-(meth)acryloxyalkyltetrahydro-1,3-oxazines, and monomers that readily generate amines by hydrolysis). Suitable polyamines can include, for example, poly(oxazolidinylethyl methacrylate), poly(vinylamine), or polyalkyleneimine (e.g., polyethyleneimine). In some embodiments, the quick setting additive is a derivatized polyamine such as an alkoxylated polyalkyleneimine (e.g., ethoxylated polyethyleneimine). Suitable derivatized polyamines are described in U.S. Application Ser. No. 61/714,497, filed Oct. 16, 2012, which is incorporated by reference herein in its entirety.


Other suitable additives that can optionally be incorporated into the composition include coalescing agents (coalescents), pH modifying agents, biocides, co-solvents and plasticizers, crosslinking agents, dispersing agents, rheology modifiers, wetting and spreading agents, leveling agents, conductivity additives, adhesion promoters, anti-blocking agents, anti-cratering agents and anti-crawling agents, anti-freezing agents, corrosion inhibitors, anti-static agents, flame retardants and intumescent additives, dyes, optical brighteners and fluorescent additives, UV absorbers and light stabilizers, chelating agents, cleanability additives, flatting agents, flocculants, humectants, insecticides, lubricants, odorants, oils, waxes and slip aids, soil repellants, stain resisting agents, and combinations thereof.


Suitable coalescents, which aid in film formation during drying, include ethylene glycol monomethyl ether, ethylene glycol monobutyl ether, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether acetate, dipropylene glycol monomethyl ether, 2,2,4-trimethyl-1,3-pentanediol monoisobutyrate, and combinations thereof.


Examples of suitable pH modifying agents include bases such as sodium hydroxide, potassium hydroxide, amino alcohols, monoethanolamine (MEA), diethanolamine (DEA), 2-(2-aminoethoxyl)ethanol, diisopropanolamine (DIPA), 1-amino-2-propanol (AMP), ammonia, and combinations thereof.


Suitable biocides can be incorporated to inhibit the growth of bacteria and other microbes in the coating composition during storage. Exemplary biocides include 2-[(hydroxymethyl)amino]ethanol, 2-[(hydroxymethyl)amino]2-methyl-1-propanol, o-phenylphenol, sodium salt, 1,2-benzisothiazolin-3-one, 2-methyl-4-isothiazolin-3-one (MIT), 5-chloro2-methyland-4-isothiazolin-3-one (CIT), 2-octyl-4-isothiazolin-3-one (OTT), 4,5-dichloro-2-n-octyl-3-isothiazolone, as well as acceptable salts and combinations thereof. Suitable biocides also include biocides that inhibit the growth of mold, mildew, and spores thereof in the coating. Examples of mildewcides include 2-(thiocyanomethylthio)benzothiazole, 3-iodo-2-propynyl butyl carbamate, 2,4,5,6-tetrachloroisophthalonitrile, 2-(4-thiazolyl)benzimidazole, 2-N-octyl4-isothiazolin-3-one, diiodomethyl p-tolyl sulfone, as well as acceptable salts and combinations thereof. In certain embodiments, the coating composition contains 1,2-benzisothiazolin-3-one or a salt thereof. Biocides of this type include PROXEL® BD20, commercially available from Arch Chemicals, Inc. The biocide can alternatively be applied as a film to the coating and a commercially available film-forming biocide is Zinc Omadine® commercially available from Arch Chemicals, Inc.


Exemplary co-solvents and humectants include ethylene glycol, propylene glycol, diethylene glycol, and combinations thereof.


Exemplary crosslinking agents include dihydrazides (e.g., dihydrazides of adipic acid, succinic acid, oxalic acid, glutamic acid, or sebastic acid). The dihydrazides can be used, for example, to crosslink diacetone acrylamide or other crosslinkable monomers.


A coating composition can be produced by combining the components as described herein. The resulting coating compositions can have a viscosity of from 12,000 to 85,000 cps at 25° C. For example, the coating compositions can have a viscosity of from 15,000 to 80,000 cps, 20,000 to 75,000 cps, 25,000 to 70,000 cps, 30,000 to 65,000 cps, 35,000 to 60,000 cps, or 40,000 to 55,000 cps at 25° C.


The volume solids percentage of the coating composition can be greater than 50%. For example, the volume solids percentage of the coating composition can be greater than 55%, greater than 60%, greater than 65%, greater than 70%, or greater than 75%.


Optionally, the weight solids percentage of the coating composition can be greater than 60%. For example, the weight solids percentage can be greater than 65%, greater than 70%, greater than 75%, or greater than 80%.


In some embodiments, the coating composition can include the following components (based on total weight of the coating composition): water 6.8-17.2% by weight, propylene glycol 0.5-2.5% by weight, pigment dispersing agent 0.4-0.85% by weight, copolymer dispersion (at 55-65% by weight copolymer) 37.8-41.3% by weight, plasticizer 0-1.0% by weight, defoamer 0.3-1.4% by weight, non-ionic surfactant 0-0.1% by weight, thickener 0.1-0.4% by weight, titanium dioxide 3.0-11.2% by weight, zinc oxide 0-3.4% by weight, calcium carbonate 27.7-33.7% by weight, talc or kaolin 0-18.3% by weight, biocide 0.1-0.3% by weight, and ammonia 0.1-0.3% by weight.


The coating composition can be applied to a substrate (e.g., as a film) and allowed to dry to form a dried coating. Generally, coatings are formed by applying a coating composition described herein to a surface, and allowing the coating to dry to form a dried coating. In some embodiments, the surface can be a substantially horizontal surface such as a roof surface. In some embodiments, the surface can be a substantially vertical surface such as a wall. Optionally, the coating composition can be applied to floors to provide moisture control to provide crack-bridging properties.


The coating composition can be applied to a surface by any suitable coating technique, including spraying, rolling, brushing, or spreading. Coating compositions can be applied in a single coat, or in multiple sequential coats (e.g., in two coats or in three coats) as required for a particular application. Generally, the coating composition is allowed to dry under ambient conditions. However, in certain embodiments, the coating composition can be dried, for example, by heating and/or by circulating air over the coating.


The coating can be co-applied with a setting accelerator to decrease the setting time of the coating on a surface. Suitable setting accelerators include compounds, such as acids, which consume the volatile base and decrease coating setting time. For example, the setting accelerator can be a dilute acid, such as acetic acid or citric acid. Setting accelerators can be applied to a surface prior to coating application, applied simultaneously with the coating composition, or applied to the coating after it has been applied to a surface but prior to drying.


The coating thickness can vary depending upon the application of the coating. For example, the coating can have a dry thickness of at least 10 mils (e.g., at least 15 mils, at least 20 mils, at least 25 mils, at least 30 mils, or at least 40 mils). In some instances, the coating has a dry thickness of less than 100 mils (e.g., less than 90 mils, less than 80 mils, less than 75 mils, less than 60 mils, less than 50 mils, less than 40 mils, less than 35 mils, or less than 30 mils). In some embodiments, the coating has a dry thickness of between 10 mils and 100 mils. In certain embodiments, the coating has a dry thickness of between 10 mils and 40 mils.


The coating composition can be applied as a film, dried, subjected to an accelerated weathering process to simulate extended field exposure for 1000 hours or more, and then subjected to the mandrel bend test set forth in ASTM D 6083-05 at −26° C. The coating composition described herein when applied as a film, dried and weathered passes the mandrel bend test set forth in ASTM D 6083-05 at −26° C. The dried and weathered coating compositions can have a tensile strength of from 200 psi or greater as set forth in ASTM D 6083-05. For example, the tensile strength of the dried and weathered coating compositions can be 250 psi or greater, 300 psi or greater, 350 psi or greater, or 400 psi or greater. Such dried and weathered coating compositions can also have an elongation at break of greater than 100% (e.g., greater than 200%, greater than 300%, or greater than 400%) as set forth in ASTM D 6083-05.


The examples below are intended to further illustrate certain aspects of the methods and compositions described herein, and are not intended to limit the scope of the claims.


EXAMPLES

Acrylic Copolymer Blends


An aqueous dispersion of acrylic copolymers was prepared by combining two copolymer dispersions, each separately prepared by emulsion polymerization. Exemplary ingredients used to prepare the coating compositions described herein are shown in Table 1.













TABLE 1






Ex. 1
Ex. 2
Ex. 3
Ex. 4


Ingredients
(wt %)
(wt %)
(wt %)
(wt %)



















Water
6.9
6.8
6.8
14.8


Propylene glycol
2.2
2.2
2.2
2.1


Pigment dispersing agent
0.5
0.5
0.5
0.4


Copolymer Dispersion 1
28.5
28.5
28.5
0.0


(Tg = −8° C.)






Defoamer
0.5
0.5
0.5
0.5


Non-ionic surfactant
0.0
0.0
0.0
0.1


Cellulosic thickener
0.0
0.0
0.0
0.1


Titanium oxide
11.2
11.2
7.8
10.2


Zinc oxide
0.0
0.0
3.4
0.0


Calcium carbonate (medium
26.4
21.9
21.9
24.3


particle size)






Calcium carbonate (fine
1.3
5.9
5.9
1.3


particle size)






Calcium carbonate (ultrafine
0.0
7.9
7.9
0.0


particle size)






Uncoated talc
18.3
0.0
0.0
7.5


Biocide
0.2
0.2
0.2
0.2


Copolymer Dispersion 2
12.8
12.8
12.8
37.8


(Tg = −28° C.)






Cellulose thickener
0.3
0.3
0.3
0.3


Ammonia
0.2
0.2
0.2
0.2


Defoamer
0.9
0.9
0.9
0.9


Total
110.2
99.8
99.8
100.7


Approximate Weight % Solids
72
72
72
66









The ingredients were mixed in the order shown in Table 1 until a homogeneous mixture was formed. The viscosities of the resulting mixtures were in the range of 12,000 to 85,000 cps at 25° C. The percentages of PVC in the mixtures were approximately 42%. The volume percentages of solids in the mixtures were approximately 59%.


Performance Properties of Comparative Example 1 and Example 5


Example 5 was prepared using 20 weight percent of D1 and 80 weight percent of D2. D1 is an acrylic copolymer containing diacetone acrylamide and adipic dihydrazide (DAAM/ADDH) room temperature crosslinking package and having a Tg of −28° C. D2 is a styrene-acrylate copolymer containing a silane crosslinker and having a Tg of −8° C. The dispersion was combined with additives listed in Table 1 to form a coating composition. The coating composition was applied as a film, dried, and weathered for 1278 hours. The resulting weathered film had a tensile strength of 390 psi, a 443% elongation at break, and a water absorption of 13.4%. The weathered film also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05. A film prepared from D2 as the only copolymer (Comparative Example 1) and including the same additives in the same amounts as Example 5 failed the mandrel bend test after weathering and under similar conditions.


Example 6 was the same as Example 5 except it used 35 weight percent of D1 and 65 weight percent of D2 as described above. The resulting weathered film had a tensile strength of 354 psi, a 387% elongation at break, and a water absorption of 13.2%. The film of Example 6 also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05.


Example 7 was the same as Example 5 except it used 50 weight percent of D1 and 50 weight percent of D2 as described above. The resulting weathered film had a tensile strength of 344 psi, a 388% elongation at break, and a water absorption of 13.6%. The film of Example 7 also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05.


The compositions, products, and methods of the appended claims are not limited in scope by the specific compositions, products, and methods described herein, which are intended as illustrations of a few aspects of the claims and any compositions, products, and methods that are functionally equivalent are intended to fall within the scope of the claims. Various modifications of the compositions, products, and methods in addition to those shown and described herein are intended to fall within the scope of the appended claims. Further, while only certain representative composition materials and method steps disclosed herein are specifically described, other combinations of the composition materials and method steps also are intended to fall within the scope of the appended claims, even if not specifically recited. Thus, a combination of steps, elements, components, or constituents may be explicitly mentioned herein; however, other combinations of steps, elements, components, and constituents are included, even though not explicitly stated. The term “comprising” and variations thereof as used herein is used synonymously with the term “including” and variations thereof and are open, non-limiting terms. Although the terms “comprising” and “including” have been used herein to describe various embodiments, the terms “consisting essentially of” and “consisting of” can be used in place of “comprising” and “including” to provide for more specific embodiments of the invention and are also disclosed.

Claims
  • 1. A coating composition, comprising a first copolymer and a second copolymer, wherein: the first copolymer is produced by emulsion polymerization and derived from one or more (meth)acrylates, one or more acid monomers, and optionally styrene, said first copolymer having a Tg from −50° C. to −23° C. and being present in an amount of 10-50% by weight based on the combined weight of the first copolymer and the second copolymer;the second copolymer is produced by emulsion polymerization and derived from one or more (meth)acrylates, one or more acid monomers, and optionally styrene, said second copolymer having a Tg from −15° C. to 25° C. and being present in an amount of 50-90% by weight based on the combined weight of the first copolymer and the second copolymer;a defoamer; anda filler comprising at least one pigment, wherein the filler is present in an amount of from 5-50% by weight, based on the coating composition;wherein at least one of the first copolymer and the second copolymer is crosslinked,wherein said coating composition has a viscosity of from 12,000 to 85,000 cps at 25° C., a volume solids of greater than 50%, and a weight solids of greater than 60%,wherein the coating composition when applied as a film, dried and weathered for 1000 hours passes the mandrel bend test at −26° C., has a tensile strength of greater than 300 psi, and an elongation at break of greater than 200% as set forth in ASTM D 6083-05.
  • 2. The coating composition of claim 1, wherein the coating composition when applied as a film, dried and weathered for 1000 hours as described in ASTM D 6083-05 has a tensile strength of greater than 300 psi to 400 psi.
  • 3. The coating composition of claim 1, wherein the at least one first copolymer is present in an amount of 20-30% by weight based on the combined weight of the first copolymer and the second copolymer.
  • 4. The coating composition of claim 1, wherein the first copolymer has a Tg of from −36° C. to −23° C.
  • 5. The coating composition of claim 1, wherein the second copolymer has a Tg of from −12° C. to 0° C.
  • 6. The coating composition of claim 1, wherein at least one of the first copolymer and the second copolymer is a styrene acrylic copolymer.
  • 7. The coating composition of claim 1, wherein the first copolymer and the second copolymer are pure acrylics.
  • 8. The coating composition of claim 1, wherein the first copolymer and the second copolymer are each derived from at least one low Tg monomer selected from the group consisting of butyl acrylate and 2-ethylhexyl acrylate.
  • 9. The coating composition of claim 1, wherein at least one of the first copolymer and the second copolymer are further derived from at least one high Tg monomer selected from the group consisting of methyl methacrylate and styrene.
  • 10. The coating composition of claim 1, wherein at least one of the first copolymer and the second copolymer is derived from a crosslinkable monomer selected from diacetone acrylamide, a 1,3-diketo-containing monomer, or a silane-containing monomer.
  • 11. The coating composition of claim 1, wherein the acid monomers in the first copolymer and the second copolymer are each selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and mixtures thereof.
  • 12. The coating composition of claim 1, wherein at least one of the first copolymer and the second copolymer is further derived from (meth)acrylamide.
  • 13. The coating composition of claim 1, further comprising a quick setting additive.
  • 14. The coating composition of claim 13, wherein the quick setting additive includes polyethyleneimine.
  • 15. The coating composition of claim 1, further comprising a setting accelerator.
  • 16. The coating composition of claim 1, wherein the filler is present in an amount of from 10-40% by weight, based on the coating composition.
  • 17. The coating composition of claim 1, wherein the filler comprises a pigment selected from metal oxides, clays, calcium carbonate, talc, barytes, feldspar, zinc sulfite, nepheline syenite, mica, pyrophyllite, perlite, wollastonite, or a combination thereof.
  • 18. The coating composition of claim 17, wherein the pigment has a mean particle size of from about 0.01 to about 50 microns.
  • 19. A composition, comprising: a first copolymer produced by emulsion polymerization and derived from one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate, said first copolymer having a Tg from −36° C. to −23° C.;a second copolymer produced by emulsion polymerization and derived from one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate, said second copolymer having a Tg from −12° C. to 0° C., anda filler comprising at least one pigment, wherein the filler is present in an amount of from 5-50% by weight, based on the composition;wherein the composition has a viscosity of from 12,000 to 85,000 cps at 25° C., andwherein the composition when applied as a film, dried and weathered for 1000 hours passes the mandrel bend test at −26° C., has a tensile strength of greater than 300 psi, and an elongation at break of greater than 200% as set forth in ASTM D 6083-05.
  • 20. The composition of claim 19, wherein the first copolymer and the second copolymer are dispersed in an aqueous medium.
  • 21. The composition of claim 20, wherein the filler is present in an amount of from 10-40% by weight, based on the composition.
  • 22. The composition of claim 19, wherein the filler comprises a pigment selected from metal oxides, clays, calcium carbonate, talc, barytes, feldspar, zinc sulfite, nepheline syenite, mica, pyrophyllite, perlite, wollastonite, or a combination thereof.
  • 23. The composition of claim 22, wherein the pigment has a mean particle size of from about 0.01 to about 50 microns.
  • 24. A dried coating, formed by drying the composition of claim 20.
  • 25. A method of coating a substrate, comprising applying the composition of claim 20 to a surface.
  • 26. The method of claim 25, wherein the surface is a roof surface.
  • 27. The method of claim 25, wherein the surface is a wall.
  • 28. The method of claim 25, wherein the method includes brushing, rolling, or spraying.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 61/754,241 filed Jan. 18, 2013, the disclosure of which is hereby incorporated by reference in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/EP2014/050197 1/8/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2014/111292 7/24/2014 WO A
US Referenced Citations (1054)
Number Name Date Kind
3549566 Mesirov Dec 1970 A
4826907 Murao May 1989 A
5219914 Warburton, Jr. Jun 1993 A
5256746 Blankenship et al. Oct 1993 A
5258423 Crabb et al. Nov 1993 A
5260131 Fukui et al. Nov 1993 A
5260350 Wright Nov 1993 A
5260400 Karydas Nov 1993 A
5262474 Minnis et al. Nov 1993 A
5262476 Laughner Nov 1993 A
5264475 Kissel Nov 1993 A
5264510 Swift et al. Nov 1993 A
5266646 Eisenhart et al. Nov 1993 A
5268417 Filges et al. Dec 1993 A
5268419 Stack et al. Dec 1993 A
5268437 Holy et al. Dec 1993 A
5270046 Sakamoto et al. Dec 1993 A
5270358 Asmus Dec 1993 A
5270389 Clouet Dec 1993 A
5270414 Saito et al. Dec 1993 A
5273706 Laughner Dec 1993 A
5274006 Kagoshima et al. Dec 1993 A
5276090 Hallden-Abberton Jan 1994 A
5276092 Kempner et al. Jan 1994 A
5278222 Stack Jan 1994 A
5278225 Kohlhammer et al. Jan 1994 A
5278271 Miyajima et al. Jan 1994 A
5279898 Evans et al. Jan 1994 A
5280073 Siol et al. Jan 1994 A
5288807 Hinz Feb 1994 A
5288828 Harris et al. Feb 1994 A
5290855 Kodama et al. Mar 1994 A
5294686 Fiarman et al. Mar 1994 A
5294688 Rehmer et al. Mar 1994 A
5296530 Bors et al. Mar 1994 A
5298554 Rehmer et al. Mar 1994 A
5298585 McCallum et al. Mar 1994 A
5300288 Albright Apr 1994 A
5300570 Ilenda et al. Apr 1994 A
5302592 Osei-Gyimah et al. Apr 1994 A
5304707 Blankenship et al. Apr 1994 A
5306762 Hutter Apr 1994 A
5308894 Laughner May 1994 A
5310810 Natoli et al. May 1994 A
5310816 Pennington et al. May 1994 A
5314943 Steinwand May 1994 A
5316860 Stewart et al. May 1994 A
5318719 Hughes et al. Jun 1994 A
5319031 Hamilton et al. Jun 1994 A
5320905 Vaughn et al. Jun 1994 A
5321056 Carson et al. Jun 1994 A
5322663 Lai et al. Jun 1994 A
5324456 Degraff Jun 1994 A
5326843 Lorah et al. Jul 1994 A
5328952 Brodnyan et al. Jul 1994 A
5328972 Dada et al. Jul 1994 A
5331018 McGinniss et al. Jul 1994 A
5332782 Liu et al. Jul 1994 A
5334450 Zabrocki et al. Aug 1994 A
5336720 Richards et al. Aug 1994 A
5338490 Dietz et al. Aug 1994 A
5338803 Sun et al. Aug 1994 A
5340858 Bauer et al. Aug 1994 A
5340871 Pearson et al. Aug 1994 A
5342884 Tabor et al. Aug 1994 A
5342899 Graham et al. Aug 1994 A
5342904 Hefner et al. Aug 1994 A
5342910 Kling et al. Aug 1994 A
5344868 Hallden-Abberton et al. Sep 1994 A
5346961 Shaw et al. Sep 1994 A
5348807 Hodder et al. Sep 1994 A
5348992 Pearson et al. Sep 1994 A
5348997 Kato et al. Sep 1994 A
5349025 Siol et al. Sep 1994 A
5352516 Therriault et al. Oct 1994 A
5356616 Sojka et al. Oct 1994 A
5360826 Egolf et al. Nov 1994 A
5362816 Snyder et al. Nov 1994 A
5368761 Gore et al. Nov 1994 A
5369169 La Fleur et al. Nov 1994 A
5371112 Sayre et al. Dec 1994 A
5371179 Paik et al. Dec 1994 A
5374674 Sojka et al. Dec 1994 A
5374684 Tai Dec 1994 A
5374686 Clikeman Dec 1994 A
5376447 Yeung et al. Dec 1994 A
5378758 Amici et al. Jan 1995 A
5380782 Bogan Jan 1995 A
5380801 Fischer et al. Jan 1995 A
5384373 McKinney et al. Jan 1995 A
5387635 Rowland et al. Feb 1995 A
5387641 Yeung et al. Feb 1995 A
5389178 Harvey Feb 1995 A
5389437 Miyajima et al. Feb 1995 A
5389726 Sojka Feb 1995 A
5393795 Hedstrand et al. Feb 1995 A
5395471 Obijeski et al. Mar 1995 A
5395882 Siol et al. Mar 1995 A
5395905 Creamer et al. Mar 1995 A
5395907 Zajaczowski Mar 1995 A
5401695 Wu Mar 1995 A
5401807 Hughes et al. Mar 1995 A
5403875 Bortnik et al. Apr 1995 A
5403894 Tsai et al. Apr 1995 A
5403903 Shimizu et al. Apr 1995 A
5405670 Wetzel et al. Apr 1995 A
5408024 Fischer et al. Apr 1995 A
5409967 Carson et al. Apr 1995 A
5413660 Harvey et al. May 1995 A
5413731 Adler et al. May 1995 A
5414047 Clikeman May 1995 A
5416148 Farah et al. May 1995 A
5416160 Johnson May 1995 A
5419967 LaFleur et al. May 1995 A
5420223 Johnson May 1995 A
5424337 Bedel et al. Jun 1995 A
5424362 Hwang et al. Jun 1995 A
5426125 Vo et al. Jun 1995 A
5426156 Bederke et al. Jun 1995 A
5430089 Harris et al. Jul 1995 A
5430101 Minematsu et al. Jul 1995 A
5433984 Ilenda et al. Jul 1995 A
5439739 Furukawa et al. Aug 1995 A
5439998 Lina et al. Aug 1995 A
5442012 Kempner et al. Aug 1995 A
5451644 Fiarman et al. Sep 1995 A
RE35049 Atherton et al. Oct 1995 E
5455321 Cummings et al. Oct 1995 A
5457156 Liu et al. Oct 1995 A
5458980 Larson Oct 1995 A
5460818 Park et al. Oct 1995 A
5461092 Laughner Oct 1995 A
5461106 Jialanella et al. Oct 1995 A
5466756 Roach et al. Nov 1995 A
5468526 Allen et al. Nov 1995 A
5468800 Foelsch et al. Nov 1995 A
5470622 Rinde et al. Nov 1995 A
5470908 Schmidt et al. Nov 1995 A
5470918 Tsutsumi et al. Nov 1995 A
5473006 Hutter et al. Dec 1995 A
5473031 Tinetti et al. Dec 1995 A
5474855 Antheunisse Dec 1995 A
5475047 Tonson et al. Dec 1995 A
5480720 Eisenhart et al. Jan 1996 A
5484849 Bors et al. Jan 1996 A
5486949 Schrenk et al. Jan 1996 A
5491192 Walker et al. Feb 1996 A
5494508 Vogel Feb 1996 A
5494971 Blankenship Feb 1996 A
5494975 LaVoie et al. Feb 1996 A
5498659 Esser Mar 1996 A
5502089 Bricker et al. Mar 1996 A
5502106 LaFleur et al. Mar 1996 A
5503767 Schwartz Apr 1996 A
5504153 Amici et al. Apr 1996 A
5506282 Min et al. Apr 1996 A
5506307 Memon Apr 1996 A
5506324 Gartner et al. Apr 1996 A
5519063 Mondet et al. May 1996 A
5519064 Stringfield et al. May 1996 A
5520767 Larson May 1996 A
5521253 Lee et al. May 1996 A
5525651 Ogoe et al. Jun 1996 A
5527613 Blankenship et al. Jun 1996 A
5532307 Bogan Jul 1996 A
5534310 Rokowski et al. Jul 1996 A
5539054 LaFleur Jul 1996 A
5543448 Laughner Aug 1996 A
5545689 Amici et al. Aug 1996 A
5547756 Kamo et al. Aug 1996 A
5548024 LaVoie et al. Aug 1996 A
5559192 Bors et al. Sep 1996 A
5562953 Bors et al. Oct 1996 A
5562958 Walton et al. Oct 1996 A
5562983 Kono et al. Oct 1996 A
5567353 Bogan Oct 1996 A
5567488 Allen et al. Oct 1996 A
5567489 Allen et al. Oct 1996 A
5567789 Manzouji et al. Oct 1996 A
5567790 Okawa Oct 1996 A
5569687 Sanborn et al. Oct 1996 A
5569710 LaFleur et al. Oct 1996 A
5573994 Kabra et al. Nov 1996 A
5576378 Kuhlmann et al. Nov 1996 A
5578247 McGinniss et al. Nov 1996 A
5580650 Forgach et al. Dec 1996 A
5599854 Troy et al. Feb 1997 A
5599890 Tang Feb 1997 A
5604288 Furukawa et al. Feb 1997 A
5605722 Esser Feb 1997 A
5605953 Esser Feb 1997 A
5605960 Brady et al. Feb 1997 A
5612397 Gebhard et al. Mar 1997 A
5612413 Rozkuszka et al. Mar 1997 A
5612820 Schrenk et al. Mar 1997 A
5614582 Hori et al. Mar 1997 A
5616638 Hallden-Abberton et al. Apr 1997 A
5618900 Drumright et al. Apr 1997 A
5622997 Tennison et al. Apr 1997 A
5623004 Bertram et al. Apr 1997 A
5625001 Makower et al. Apr 1997 A
5629377 Burgert et al. May 1997 A
5633316 Gartner et al. May 1997 A
5633335 Manzouji et al. May 1997 A
5635574 Aoyagi et al. Jun 1997 A
5643993 Guerin Jul 1997 A
5652289 Eisenhart et al. Jul 1997 A
5652292 Stanley Jul 1997 A
5652293 Eisenhart et al. Jul 1997 A
5652305 Amici et al. Jul 1997 A
5652306 Meyer et al. Jul 1997 A
5654365 Havriliak et al. Aug 1997 A
5654366 Furukawa et al. Aug 1997 A
5658965 Manzouji et al. Aug 1997 A
5663213 Jones et al. Sep 1997 A
5663241 Takamatsu et al. Sep 1997 A
5663259 Treybig et al. Sep 1997 A
5672379 Schall et al. Sep 1997 A
5672656 Murayama et al. Sep 1997 A
5674934 Schmidt et al. Oct 1997 A
5674943 Farah et al. Oct 1997 A
5679732 Van Rheenen Oct 1997 A
5681880 Desor et al. Oct 1997 A
5686528 Willis et al. Nov 1997 A
5693704 Estes Dec 1997 A
5693716 Bott et al. Dec 1997 A
5700867 Ishiyama et al. Dec 1997 A
5700873 Zajaczkowski et al. Dec 1997 A
5700885 Pham et al. Dec 1997 A
5703157 Fujiwara et al. Dec 1997 A
5705560 Takarabe et al. Jan 1998 A
5710227 Freeman et al. Jan 1998 A
5712031 Kelch et al. Jan 1998 A
5714537 Laughner et al. Feb 1998 A
5717000 Karande et al. Feb 1998 A
5723182 Choi et al. Mar 1998 A
5731377 Friel Mar 1998 A
5731379 Kennan et al. Mar 1998 A
5741594 Jialanella Apr 1998 A
5744564 Stanley et al. Apr 1998 A
5750587 Manzouji et al. May 1998 A
5753766 Bott et al. May 1998 A
5755972 Hann et al. May 1998 A
5756659 Hughes et al. May 1998 A
5763012 Zhao et al. Jun 1998 A
5766908 Klein et al. Jun 1998 A
5767213 Graham et al. Jun 1998 A
5777034 Shah et al. Jul 1998 A
5783626 Taylor et al. Jul 1998 A
5786424 Hofmeister et al. Jul 1998 A
5804254 Nedwick et al. Sep 1998 A
5804632 Haddleton et al. Sep 1998 A
5817712 Weinberger et al. Oct 1998 A
5820993 Schall et al. Oct 1998 A
5821283 Hesler et al. Oct 1998 A
5821295 Nakayama et al. Oct 1998 A
5824762 Saruyama et al. Oct 1998 A
5837762 Stollmaier et al. Nov 1998 A
5837766 Metro et al. Nov 1998 A
5840428 Blizzard et al. Nov 1998 A
5846657 Wu Dec 1998 A
5856409 Ziemelis et al. Jan 1999 A
5856611 Schlaefer et al. Jan 1999 A
5859112 Overbeek et al. Jan 1999 A
5863999 Kinker et al. Jan 1999 A
5866664 McCallum et al. Feb 1999 A
5869590 Clark et al. Feb 1999 A
5869591 McKay et al. Feb 1999 A
5879759 Zang Mar 1999 A
5883188 Hwang et al. Mar 1999 A
5885746 Iwai et al. Mar 1999 A
5891950 Collins et al. Apr 1999 A
5900462 Tanaka May 1999 A
5910358 Thoen et al. Jun 1999 A
5910532 Schmidt et al. Jun 1999 A
5912293 Stockwell et al. Jun 1999 A
5916960 Lum et al. Jun 1999 A
5916967 Jones et al. Jun 1999 A
5919849 Memon et al. Jul 1999 A
5922410 Swartz et al. Jul 1999 A
5922789 Kohlhammer et al. Jul 1999 A
5928206 Miyake et al. Jul 1999 A
5928730 Nakayama Jul 1999 A
5929128 Whetten et al. Jul 1999 A
5929172 Zajaczkowski Jul 1999 A
5932350 Lauer et al. Aug 1999 A
5948874 Pike et al. Sep 1999 A
5959016 Schmidt et al. Sep 1999 A
5962545 Chaudhary et al. Oct 1999 A
5962556 Taylor Oct 1999 A
5962571 Overbeek et al. Oct 1999 A
5962609 Haddleton et al. Oct 1999 A
5969046 Schindler et al. Oct 1999 A
5969063 Parker et al. Oct 1999 A
5972363 Clikeman et al. Oct 1999 A
5977194 Mork et al. Nov 1999 A
5977271 McKay et al. Nov 1999 A
5977274 Leblanc et al. Nov 1999 A
5981642 Overbeek et al. Nov 1999 A
5981666 Zajaczkowski et al. Nov 1999 A
5986003 Lee et al. Nov 1999 A
5988455 Pearson et al. Nov 1999 A
5997952 Harris et al. Dec 1999 A
5997969 Gardon Dec 1999 A
5998514 Cheng et al. Dec 1999 A
5998543 Collins et al. Dec 1999 A
6005042 Desor et al. Dec 1999 A
6010783 Tung Jan 2000 A
6013732 Yamana et al. Jan 2000 A
6017721 Butz Jan 2000 A
6017848 Mando et al. Jan 2000 A
6025404 Harris et al. Feb 2000 A
6031047 Brady et al. Feb 2000 A
6040386 Iliopoulo et al. Mar 2000 A
6040409 Lau et al. Mar 2000 A
6051633 Tomko et al. Apr 2000 A
6057400 Kinney et al. May 2000 A
6060556 Collins et al. May 2000 A
6063823 Nakatani et al. May 2000 A
6072013 Manzouji et al. Jun 2000 A
6077527 Tan et al. Jun 2000 A
6084029 McGee Jul 2000 A
6084044 Roe et al. Jul 2000 A
6087425 Eisenhart et al. Jul 2000 A
6087447 Stevens et al. Jul 2000 A
6090875 Staples et al. Jul 2000 A
6090882 Trumbo et al. Jul 2000 A
6090902 Kuo et al. Jul 2000 A
6096669 Colegrove et al. Aug 2000 A
6113978 Ornstein et al. Sep 2000 A
6120638 Baxter et al. Sep 2000 A
6124370 Walton et al. Sep 2000 A
6136883 Yang et al. Oct 2000 A
6136896 Lee et al. Oct 2000 A
6140431 Kinker et al. Oct 2000 A
6143829 Babb et al. Nov 2000 A
6153690 Larson et al. Nov 2000 A
6160029 Chaudhary et al. Dec 2000 A
6160044 Jimbo et al. Dec 2000 A
6160057 Webster et al. Dec 2000 A
6168866 Clark Jan 2001 B1
6183829 Daecher et al. Feb 2001 B1
6184294 Park et al. Feb 2001 B1
6187834 Thayer et al. Feb 2001 B1
6191244 Lau et al. Feb 2001 B1
6194525 Ortiz et al. Feb 2001 B1
6197382 Ornstein et al. Mar 2001 B1
6201067 Cheung et al. Mar 2001 B1
6207780 Stockhausen et al. Mar 2001 B1
6218464 Parker et al. Apr 2001 B1
6218491 Fu et al. Apr 2001 B1
6221448 Baetzold et al. Apr 2001 B1
6225242 Lau et al. May 2001 B1
6228201 Cooper et al. May 2001 B1
6228901 Brown et al. May 2001 B1
6228913 Owens et al. May 2001 B1
6228949 Webster et al. May 2001 B1
6232417 Rhodes et al. May 2001 B1
6235814 Bowe May 2001 B1
6238795 Strom et al. May 2001 B1
6239209 Yang et al. May 2001 B1
6239228 Zajaczkowski et al. May 2001 B1
6242515 Zhao et al. Jun 2001 B1
6242526 Siddiqui et al. Jun 2001 B1
6242528 Clark et al. Jun 2001 B1
6245711 Halbrook Jun 2001 B1
6248826 Solomon et al. Jun 2001 B1
6251213 Bartman et al. Jun 2001 B1
6251485 Harris et al. Jun 2001 B1
6251680 Fu et al. Jun 2001 B1
6251973 Robinson et al. Jun 2001 B1
6251988 Blum et al. Jun 2001 B1
6254956 Kjellqvist et al. Jul 2001 B1
6255381 Park et al. Jul 2001 B1
6260715 Simard et al. Jul 2001 B1
6262149 Clark et al. Jul 2001 B1
6262161 Betso et al. Jul 2001 B1
6262169 Helmer et al. Jul 2001 B1
6265514 Warren et al. Jul 2001 B1
6277437 Helmer et al. Aug 2001 B1
6280808 Fields et al. Aug 2001 B1
6291021 Morita et al. Sep 2001 B1
6297328 Collins et al. Oct 2001 B1
6300407 Machleder et al. Oct 2001 B1
6300409 Lau et al. Oct 2001 B2
6303186 Bors et al. Oct 2001 B1
6303188 Bors et al. Oct 2001 B1
6306962 Pham et al. Oct 2001 B1
6306969 Patel et al. Oct 2001 B1
6306991 Fischer et al. Oct 2001 B1
6310112 Vo et al. Oct 2001 B1
6310125 Rayner Oct 2001 B1
6310159 Eiffler et al. Oct 2001 B1
6322860 Stein et al. Nov 2001 B1
6325939 Strom et al. Dec 2001 B2
6326449 Haldankar Dec 2001 B1
6331580 Molnar Dec 2001 B1
6333378 Clark et al. Dec 2001 B1
6335404 Kirk et al. Jan 2002 B1
6337366 Amick et al. Jan 2002 B1
6338801 Strom et al. Jan 2002 B2
6344502 Babjak et al. Feb 2002 B1
6346300 Ruepping Feb 2002 B1
6348623 Webster et al. Feb 2002 B2
6358620 Yokelson et al. Mar 2002 B1
6359110 Mussell et al. Mar 2002 B1
6361768 Galleguillos et al. Mar 2002 B1
6362274 Legrand et al. Mar 2002 B1
6368575 Chang et al. Apr 2002 B2
6369182 Whipple et al. Apr 2002 B1
6372831 Sikkema et al. Apr 2002 B1
6372871 Jimbo et al. Apr 2002 B1
6376574 Helmer et al. Apr 2002 B1
6376600 Solomon et al. Apr 2002 B1
6380303 Ogoe et al. Apr 2002 B1
6380304 Vanspeybroeck et al. Apr 2002 B1
6383569 Ornstein et al. May 2002 B2
6384104 Chang et al. May 2002 B1
6384131 Kinney et al. May 2002 B1
6387167 Haldankar May 2002 B1
6395813 Duccini et al. May 2002 B1
6395836 Shinoda May 2002 B1
6399171 Merlin et al. Jun 2002 B1
6417267 Stockl et al. Jul 2002 B1
6419830 Strom et al. Jul 2002 B2
6423382 Bowe et al. Jul 2002 B1
6423416 Nanavati Jul 2002 B1
6423805 Bacho et al. Jul 2002 B1
6433058 Weir et al. Aug 2002 B1
6433098 Brown et al. Aug 2002 B1
6436421 Schindler et al. Aug 2002 B1
6436498 Rangwalla et al. Aug 2002 B1
6441082 Weitzel et al. Aug 2002 B1
6444749 Mestach Sep 2002 B2
6447845 Nanavati et al. Sep 2002 B1
6451403 Daecher et al. Sep 2002 B1
6451899 Zhao et al. Sep 2002 B1
6451912 Kelch Sep 2002 B1
6451951 Beckley et al. Sep 2002 B2
6455161 Regnier et al. Sep 2002 B1
6458458 Cooke et al. Oct 2002 B1
6458878 Tsuboi et al. Oct 2002 B1
6465558 Scheibelhoffer et al. Oct 2002 B2
6465563 Mori et al. Oct 2002 B1
6471885 Chiang et al. Oct 2002 B2
6472452 Ruepping Oct 2002 B2
6475556 Sobczak et al. Nov 2002 B1
6476168 Dahanayake et al. Nov 2002 B1
6479571 Cooke et al. Nov 2002 B1
6482502 Fields et al. Nov 2002 B1
6482886 Finlayson et al. Nov 2002 B1
6489381 Dreher et al. Dec 2002 B1
6489385 Fujii et al. Dec 2002 B1
6492445 Siddiqui et al. Dec 2002 B2
6492450 Hsu Dec 2002 B1
6503992 Mitchell et al. Jan 2003 B2
6514584 Merlin et al. Feb 2003 B1
6515041 Hayashi et al. Feb 2003 B2
6515042 Kriessmann et al. Feb 2003 B2
6515082 Brown et al. Feb 2003 B1
6518348 Lee et al. Feb 2003 B1
6521696 Oates et al. Feb 2003 B2
6525161 Hall Feb 2003 B1
6528581 Kelly et al. Mar 2003 B1
6528593 Eiffler et al. Mar 2003 B1
6534592 Chou et al. Mar 2003 B1
6538062 Sakaguchi et al. Mar 2003 B2
6541088 Rangwalla et al. Apr 2003 B1
6541571 Haldankar Apr 2003 B1
6548596 Kohr et al. Apr 2003 B1
6552129 Babb et al. Apr 2003 B2
6555641 Parker et al. Apr 2003 B2
6558688 Saishin et al. May 2003 B2
6558809 Kelch et al. May 2003 B1
6559193 Nonoyama et al. May 2003 B2
6559231 Hasegawa et al. May 2003 B2
6566466 Zajaczkowski May 2003 B1
6566469 Kaplan et al. May 2003 B1
6569976 Baxter et al. May 2003 B2
6572965 McGee et al. Jun 2003 B1
6579958 Wilson Jun 2003 B2
6586097 Pascault et al. Jul 2003 B1
6586501 Dalton et al. Jul 2003 B1
6586512 Dukes et al. Jul 2003 B1
6590006 Park et al. Jul 2003 B2
6593399 La Fleur et al. Jul 2003 B1
6602557 Ruepping Aug 2003 B2
6605359 Robinson et al. Aug 2003 B2
6610282 Ghosh Aug 2003 B1
6613827 Lundgard et al. Sep 2003 B2
6617267 Soane et al. Sep 2003 B2
6620474 Regnier et al. Sep 2003 B1
6624212 Weier et al. Sep 2003 B2
6627670 Mork et al. Sep 2003 B2
6627679 Kling Sep 2003 B1
6630533 Konopka et al. Oct 2003 B2
6632861 Weitzel et al. Oct 2003 B1
6632879 Brann et al. Oct 2003 B2
6632906 Kamiyama Oct 2003 B1
6639012 Wills et al. Oct 2003 B2
6642335 Kawase et al. Nov 2003 B2
6646058 Koger Nov 2003 B1
6646082 Ghosh et al. Nov 2003 B2
6646086 Slone Nov 2003 B2
6646091 Taylor et al. Nov 2003 B2
6656979 Kitano et al. Dec 2003 B1
6657011 Lau et al. Dec 2003 B2
6657014 Mori et al. Dec 2003 B1
6660394 Ishizuki et al. Dec 2003 B1
6663974 Kelch et al. Dec 2003 B2
6664327 Daisey et al. Dec 2003 B2
6669953 Kamiyama Dec 2003 B1
6670419 Lau et al. Dec 2003 B2
6683120 Munro et al. Jan 2004 B2
6683132 Schick et al. Jan 2004 B1
6686008 Merlin et al. Feb 2004 B1
6686321 Boden et al. Feb 2004 B2
6689200 Scarborough et al. Feb 2004 B2
6691715 Matz et al. Feb 2004 B2
6693151 Throne et al. Feb 2004 B2
6703433 Bahadur et al. Mar 2004 B1
6706216 Malz et al. Mar 2004 B1
6706217 Malz et al. Mar 2004 B2
6706779 Bahadur et al. Mar 2004 B2
6706818 Ishihara et al. Mar 2004 B2
6710128 Helmer et al. Mar 2004 B1
6716912 Freeman et al. Apr 2004 B2
6716929 Wilson Apr 2004 B2
6723486 Goodall et al. Apr 2004 B2
6723764 Sakabe Apr 2004 B2
6723775 Lau et al. Apr 2004 B2
6727314 Burghart et al. Apr 2004 B2
6730718 Jakob May 2004 B1
6730734 Hamilton et al. May 2004 B1
6730740 Mestach et al. May 2004 B1
6740358 Speece et al. May 2004 B2
6743844 Tabor et al. Jun 2004 B1
6753355 Stollmaier et al. Jun 2004 B2
6756075 DeMasi et al. Jun 2004 B2
6756459 Larson et al. Jun 2004 B2
6759463 Lorah et al. Jul 2004 B2
6759484 Murayama et al. Jul 2004 B1
6762241 Blum et al. Jul 2004 B1
6765049 Lorah et al. Jul 2004 B2
6767931 Martinez et al. Jul 2004 B2
6770285 Keenan et al. Aug 2004 B2
6784239 Wada et al. Aug 2004 B2
6794042 Merlin et al. Sep 2004 B1
6803390 Lekovic et al. Oct 2004 B2
6812309 Clark Nov 2004 B2
6812366 Lin Nov 2004 B2
6815475 Donald et al. Nov 2004 B2
6818684 Slone Nov 2004 B2
6844065 Reddy et al. Jan 2005 B2
6846564 Pascault et al. Jan 2005 B1
6848777 Chen et al. Feb 2005 B2
6849681 Hutter et al. Feb 2005 B2
6852819 Ohnishi et al. Feb 2005 B2
6858299 Lundquist et al. Feb 2005 B2
6861475 Ilenda et al. Mar 2005 B2
6864309 Lau et al. Mar 2005 B2
6869996 Krajnik et al. Mar 2005 B1
6870011 MacQueen et al. Mar 2005 B2
6875797 Redlich et al. Apr 2005 B2
6875820 Berard et al. Apr 2005 B2
6878776 Pascault et al. Apr 2005 B1
6884468 Abundis et al. Apr 2005 B1
6884843 Kauffman et al. Apr 2005 B2
6887574 Dean et al. May 2005 B2
6887960 Parker et al. May 2005 B2
6893722 McGee May 2005 B2
6900249 Mork et al. May 2005 B2
6914091 Donald et al. Jul 2005 B2
6914095 Lorah et al. Jul 2005 B2
6914099 Kim Jul 2005 B2
6919400 Nungesser et al. Jul 2005 B2
6924011 Aert et al. Aug 2005 B2
6931809 Brown et al. Aug 2005 B1
6939922 Beckley et al. Sep 2005 B2
6943231 Bühler Sep 2005 B2
6951598 Flugge et al. Oct 2005 B2
6953501 Herbert et al. Oct 2005 B2
6967227 Hutter Nov 2005 B1
6969756 Brennan et al. Nov 2005 B2
6982288 Mitra et al. Jan 2006 B2
6987151 Gartner et al. Jan 2006 B2
6989191 Weissgerber et al. Jan 2006 B2
6992121 Peters et al. Jan 2006 B1
6998435 Hungrige et al. Feb 2006 B1
7025825 Pyzik et al. Apr 2006 B2
7025853 Kesselmayer Apr 2006 B2
7071256 Green Jul 2006 B2
7071260 Kuropka Jul 2006 B1
7073671 Charkoudian Jul 2006 B2
7077981 Wehner et al. Jul 2006 B2
7101924 Von Schmittou et al. Sep 2006 B2
7112616 Takizawa et al. Sep 2006 B2
7115682 Guo et al. Oct 2006 B2
7132468 Tepe Nov 2006 B2
7132489 Lee et al. Nov 2006 B2
7138139 Gauthier et al. Nov 2006 B2
7150787 Clamen et al. Dec 2006 B2
7159655 Ke et al. Jan 2007 B2
7160957 Kuriyama et al. Jan 2007 B2
7173074 Mitra et al. Feb 2007 B2
7186769 Von Schmittou et al. Mar 2007 B2
7186773 Araki et al. Mar 2007 B2
7199180 Simmons et al. Apr 2007 B1
7208544 Kawase et al. Apr 2007 B2
7211613 Lorah et al. May 2007 B2
7214728 Kimpimaki et al. May 2007 B2
7214737 Albalat Perez et al. May 2007 B2
7217443 Bobsein et al. May 2007 B2
7220338 Chen et al. May 2007 B2
7220802 Julien et al. May 2007 B2
7226887 Wehmeyer Jun 2007 B2
7226955 Subramonian et al. Jun 2007 B2
7232862 Odagawa et al. Jun 2007 B2
7238732 Bamborough et al. Jul 2007 B2
7238742 Weese et al. Jul 2007 B2
7244784 Amick et al. Jul 2007 B2
7247694 Stein et al. Jul 2007 B2
7253307 Carlson et al. Aug 2007 B1
7256227 Stone Aug 2007 B2
7259203 Chou et al. Aug 2007 B2
7262242 Gielens et al. Aug 2007 B2
7270180 Ke et al. Sep 2007 B2
7271202 Krabbenborg et al. Sep 2007 B2
7273842 VanDyk et al. Sep 2007 B1
7285585 Coyle et al. Oct 2007 B2
7285590 Holub et al. Oct 2007 B2
7309729 Weese et al. Dec 2007 B1
7312277 Maes et al. Dec 2007 B2
7312292 Ravikiran et al. Dec 2007 B2
7323078 Berezuk et al. Jan 2008 B2
7323527 Bohling et al. Jan 2008 B1
7329722 Vaitkeviciene et al. Feb 2008 B2
7332540 Theelen et al. Feb 2008 B2
7344811 Michaleviciute et al. Mar 2008 B2
7347988 Hu et al. Mar 2008 B2
7361710 Thames et al. Apr 2008 B2
7364774 Urscheler et al. Apr 2008 B2
7375096 Davis et al. May 2008 B1
7393887 Friedrich et al. Jul 2008 B2
7396561 Rühe Jul 2008 B2
7396871 Shoaf et al. Jul 2008 B2
7399810 Creamer et al. Jul 2008 B2
7399818 Bromm et al. Jul 2008 B2
7405169 Lu Jul 2008 B2
7411008 Tucker et al. Aug 2008 B2
7414091 Chen et al. Aug 2008 B2
7417086 Griffith et al. Aug 2008 B2
7425246 Urscheler Sep 2008 B2
7445849 Apitz et al. Nov 2008 B2
7452935 Slone et al. Nov 2008 B2
7452952 Kohr et al. Nov 2008 B2
7455892 Goodwin et al. Nov 2008 B2
7459496 Hsu et al. Dec 2008 B2
7470751 Taylor et al. Dec 2008 B2
7479521 Braun et al. Jan 2009 B2
7504466 Devonport et al. Mar 2009 B2
7507436 Nakano et al. Mar 2009 B2
7510623 Lutz et al. Mar 2009 B2
7517591 Miyoshi et al. Apr 2009 B2
7520559 Vo et al. Apr 2009 B2
7521099 Ochi et al. Apr 2009 B2
7521100 Imaizumi et al. Apr 2009 B2
7521101 Naisby et al. Apr 2009 B2
7531600 Rey May 2009 B1
7534843 Jialanella et al. May 2009 B2
7537802 Rosano May 2009 B2
7538151 Fernandes et al. May 2009 B2
7538153 Bacher et al. May 2009 B2
7544401 Dungworth et al. Jun 2009 B2
7547745 Valette Jun 2009 B2
7557158 VanRheenen Jul 2009 B2
7557235 Lai et al. Jul 2009 B2
7557372 Yang et al. Jul 2009 B2
7563836 Pierni et al. Jul 2009 B2
7572840 Kleijn et al. Aug 2009 B2
7572843 Renz et al. Aug 2009 B2
7576157 Pajerski Aug 2009 B2
7579081 Brown Aug 2009 B2
7585915 Jakob et al. Sep 2009 B2
7592412 Cray et al. Sep 2009 B2
7608655 Hunig et al. Oct 2009 B2
7612145 Azimipour et al. Nov 2009 B2
7618693 Dungworth et al. Nov 2009 B2
7625687 Hu et al. Dec 2009 B2
7629414 Bardman et al. Dec 2009 B2
7637961 El A'mma et al. Dec 2009 B2
7638176 Kasperchik et al. Dec 2009 B2
7638579 Finch et al. Dec 2009 B2
7648034 Charkoudian et al. Jan 2010 B2
7648767 Fu et al. Jan 2010 B2
7678156 Gross et al. Mar 2010 B2
7678433 Ochi et al. Mar 2010 B2
7683110 Schlesiger et al. Mar 2010 B2
7683131 Goldacker et al. Mar 2010 B2
7687561 Misiak Mar 2010 B1
7691942 Bardman et al. Apr 2010 B2
7700703 Hughes et al. Apr 2010 B2
7709555 Stappers et al. May 2010 B2
7718731 Cogordan et al. May 2010 B2
7723850 Gallagher et al. May 2010 B2
7732506 Wang et al. Jun 2010 B2
7732525 Branston et al. Jun 2010 B2
7741401 Harris et al. Jun 2010 B2
7741402 Bobsein et al. Jun 2010 B2
7745546 MacQueen et al. Jun 2010 B2
7754300 Beyer et al. Jul 2010 B2
7759404 Burgun et al. Jul 2010 B2
7767747 Lind et al. Aug 2010 B2
7767770 Han et al. Aug 2010 B2
7780744 Shah et al. Aug 2010 B2
7790244 Dungworth et al. Sep 2010 B2
7794565 Shannon et al. Sep 2010 B2
7803864 Bobsein et al. Sep 2010 B2
7807271 Branston et al. Oct 2010 B2
7807739 Obst et al. Oct 2010 B2
7807765 Ghosh et al. Oct 2010 B2
7820754 Betremieux et al. Oct 2010 B2
7824746 Imaizumi et al. Nov 2010 B2
7829611 Kelly Nov 2010 B2
7829631 Wu et al. Nov 2010 B2
7834087 Joffre et al. Nov 2010 B2
7842755 Morita et al. Nov 2010 B2
7847016 Turek et al. Dec 2010 B2
7851575 Ravikiran et al. Dec 2010 B2
7858197 Ahn et al. Dec 2010 B2
7875355 Rouge et al. Jan 2011 B2
7893157 Troy et al. Feb 2011 B2
7893162 Lafleur et al. Feb 2011 B2
7897689 Harris et al. Mar 2011 B2
7906591 Weinstein et al. Mar 2011 B2
7910663 Taylor et al. Mar 2011 B2
7910680 White et al. Mar 2011 B2
7914645 Schalau et al. Mar 2011 B2
7923503 Takahashi et al. Apr 2011 B2
7931963 Maurer et al. Apr 2011 B2
7939169 McGee et al. May 2011 B2
7947760 Janmaat et al. May 2011 B2
7947776 Moncla et al. May 2011 B2
7947790 Katsurao et al. May 2011 B2
7951429 Miller May 2011 B2
7951884 Birkett et al. May 2011 B1
7955696 Baikerikar et al. Jun 2011 B2
7955702 Schwoeppe et al. Jun 2011 B2
7956132 Arriola et al. Jun 2011 B2
7968619 Cottrell et al. Jun 2011 B2
7968641 Killilea Jun 2011 B2
7968650 Tighe et al. Jun 2011 B2
7981327 Sakaguchi et al. Jul 2011 B2
7981512 Tamori et al. Jul 2011 B2
7981950 O'Donnell et al. Jul 2011 B2
7985795 Bobsein et al. Jul 2011 B2
7985809 Krawczyk et al. Jul 2011 B2
7989082 Vanrheenen Aug 2011 B2
7989505 Hu et al. Aug 2011 B2
7998531 Wevers et al. Aug 2011 B2
7999030 Thames et al. Aug 2011 B2
7999040 Patil et al. Aug 2011 B2
8007978 Klier et al. Aug 2011 B2
8008396 Rohrbach et al. Aug 2011 B2
8013058 Ahn et al. Sep 2011 B2
8013068 Beckley et al. Sep 2011 B2
8013092 Krajnik et al. Sep 2011 B1
8025758 Loehden et al. Sep 2011 B2
8034869 Bobsein et al. Oct 2011 B2
8034871 Bochnik et al. Oct 2011 B2
8043476 Haigh et al. Oct 2011 B2
8048961 Arriola et al. Nov 2011 B2
8053503 Moncla et al. Nov 2011 B2
8058349 Montoya-Goni et al. Nov 2011 B2
8062745 McGee et al. Nov 2011 B2
8062994 Masuda et al. Nov 2011 B2
8063128 Moncla et al. Nov 2011 B2
8063143 Morita et al. Nov 2011 B2
8071658 Zhou et al. Dec 2011 B2
8080612 Troy et al. Dec 2011 B2
8084543 Lafleur et al. Dec 2011 B2
8088252 Farwaha et al. Jan 2012 B2
8088547 Hu et al. Jan 2012 B2
8092727 Maurer et al. Jan 2012 B2
8124689 Loubert et al. Feb 2012 B2
8128946 Kawamura et al. Mar 2012 B2
8129442 Ueyama et al. Mar 2012 B2
8133961 Hsu et al. Mar 2012 B2
8133963 Pierini et al. Mar 2012 B2
8137754 Lai et al. Mar 2012 B2
8153721 Balk et al. Apr 2012 B2
8158711 Moncla et al. Apr 2012 B2
8158713 Finegan et al. Apr 2012 B2
8163206 Chang et al. Apr 2012 B2
8163837 Moncla et al. Apr 2012 B2
8168736 Schmitt et al. May 2012 B2
8178168 O'Neill et al. May 2012 B2
8178600 Kelly May 2012 B2
8178624 Schultes et al. May 2012 B2
8192844 Numrich et al. Jun 2012 B2
8193275 Moncla et al. Jun 2012 B2
8193278 Demarest et al. Jun 2012 B2
8198376 Kobushi et al. Jun 2012 B2
8202946 Patil et al. Jun 2012 B2
8207267 Von Tschammer et al. Jun 2012 B2
8211982 Harris et al. Jul 2012 B2
8227085 Kishikawa et al. Jul 2012 B2
8227520 Shirasaki et al. Jul 2012 B2
8227542 Bardman et al. Jul 2012 B2
8227549 Schultes et al. Jul 2012 B2
8232334 Kelly et al. Jul 2012 B2
8232336 Moncla et al. Jul 2012 B2
8236431 Mukkamala Aug 2012 B2
8236975 Hook et al. Aug 2012 B2
8252425 Lee et al. Aug 2012 B2
8263679 Zhou et al. Sep 2012 B2
8263720 Salamone et al. Sep 2012 B1
8273822 Rossi et al. Sep 2012 B2
8283404 Allen et al. Oct 2012 B2
8299153 Kelly Oct 2012 B2
8304485 Allen et al. Nov 2012 B2
8304517 Morimitsu et al. Nov 2012 B2
8304563 Kruper et al. Nov 2012 B2
8308855 Togashi et al. Nov 2012 B2
8309634 Beyer et al. Nov 2012 B2
8309651 Finch et al. Nov 2012 B2
8309669 Schmitt et al. Nov 2012 B2
8313604 Oshima et al. Nov 2012 B2
8324311 Wasserman et al. Dec 2012 B2
8329797 Eaton et al. Dec 2012 B2
8334021 Hoefler et al. Dec 2012 B2
8334346 Hibben Dec 2012 B2
8344046 Tucker et al. Jan 2013 B2
8349929 Kainz et al. Jan 2013 B2
8357749 Malotky et al. Jan 2013 B2
8377852 Ahn et al. Feb 2013 B2
8389113 Ambrose et al. Mar 2013 B2
8404759 Phelan Mar 2013 B2
8415404 Nicolson et al. Apr 2013 B2
8415422 Schuetz et al. Apr 2013 B2
8426637 Koestner et al. Apr 2013 B2
8431229 Schmitt et al. Apr 2013 B2
8440300 Sharavanan et al. May 2013 B2
8470120 Killat et al. Jun 2013 B2
8475878 Claasen et al. Jul 2013 B2
8491729 Bammel et al. Jul 2013 B2
8492465 Seibold et al. Jul 2013 B2
8492472 Elizalde et al. Jul 2013 B2
8492576 Lai et al. Jul 2013 B2
8497337 Herfert et al. Jul 2013 B2
8501832 Tighe et al. Aug 2013 B2
8507622 Lemonds et al. Aug 2013 B2
8513356 Sharma et al. Aug 2013 B1
8519043 Hartig et al. Aug 2013 B2
8524800 Phelan Sep 2013 B2
8530362 Nungesser et al. Sep 2013 B2
8530579 Arriola et al. Sep 2013 B2
8530591 Yang et al. Sep 2013 B2
8540358 Mozel et al. Sep 2013 B2
8552119 Hibben Oct 2013 B2
8557921 Arriola et al. Oct 2013 B2
8580875 Lee et al. Nov 2013 B2
8592518 Bailey et al. Nov 2013 B2
8598369 Hauck et al. Dec 2013 B2
8609759 Fasano et al. Dec 2013 B2
8609779 Harris et al. Dec 2013 B2
8609780 Misiak et al. Dec 2013 B2
8609795 Sugimoto et al. Dec 2013 B2
8641846 Parsons et al. Feb 2014 B2
8648130 Hasegawa et al. Feb 2014 B2
8658742 Dombrowski et al. Feb 2014 B2
8697810 Vogel et al. Apr 2014 B2
8703194 Liu et al. Apr 2014 B2
8709543 Lai et al. Apr 2014 B2
8710150 Chang et al. Apr 2014 B2
8722787 Romick et al. May 2014 B2
8733369 Rees et al. May 2014 B2
8734817 Hossainy et al. May 2014 B2
8741427 Kim et al. Jun 2014 B2
8742016 Besser et al. Jun 2014 B2
8747969 Lu Jun 2014 B2
8765822 Braun et al. Jul 2014 B2
8779051 Kisin et al. Jul 2014 B2
8779053 Lundgard et al. Jul 2014 B2
8790632 Arthur Jul 2014 B2
8791190 Pressley et al. Jul 2014 B2
8802238 Zheng et al. Aug 2014 B2
20010044482 Hu et al. Nov 2001 A1
20010056153 Nakagome Dec 2001 A1
20020037956 Avramidis et al. Mar 2002 A1
20020077435 DeSimone et al. Jun 2002 A1
20020103278 Krajnik et al. Aug 2002 A1
20020115795 Shang et al. Aug 2002 A1
20020155235 Taylor et al. Oct 2002 A1
20020168533 Taylor et al. Nov 2002 A1
20030065068 Inukai et al. Apr 2003 A1
20030139496 Sugishima et al. Jul 2003 A1
20030147835 Munro et al. Aug 2003 A1
20030158324 Maxim Aug 2003 A1
20030224184 Hermes et al. Dec 2003 A1
20030225183 De Putter et al. Dec 2003 A1
20030232933 Lagneaux et al. Dec 2003 A1
20040044124 Hutter et al. Mar 2004 A1
20040054026 Kunzler et al. Mar 2004 A1
20040054043 Friedrich et al. Mar 2004 A1
20050075428 Ddamulira et al. Apr 2005 A1
20050129769 Barry et al. Jun 2005 A1
20050176874 Panades et al. Aug 2005 A1
20050215746 DeSimone et al. Sep 2005 A1
20050238884 Peters et al. Oct 2005 A1
20050239957 Pillsbury et al. Oct 2005 A1
20050288410 Farcet Dec 2005 A1
20060004140 Asano et al. Jan 2006 A1
20060069171 Prokopowicz et al. Mar 2006 A1
20060079609 Nishioka et al. Apr 2006 A1
20060089453 Pajerski Apr 2006 A1
20060099347 Sugeta et al. May 2006 A1
20060100352 Arnold et al. May 2006 A1
20060135649 Jedlicka et al. Jun 2006 A1
20060167206 Maier et al. Jul 2006 A1
20060235124 Wehner et al. Oct 2006 A1
20060247367 Guo et al. Nov 2006 A1
20070027249 Killilea Feb 2007 A1
20070032605 Harashina Feb 2007 A1
20070055017 Schultes et al. Mar 2007 A1
20070066777 Bzowej et al. Mar 2007 A1
20070093575 Murakami et al. Apr 2007 A1
20070129486 Klein et al. Jun 2007 A1
20070142565 Chaudhary et al. Jun 2007 A1
20070149641 Goupil et al. Jun 2007 A1
20070149711 Chaudhary et al. Jun 2007 A1
20070155862 Haerzschel et al. Jul 2007 A1
20070173613 Chaudhary et al. Jul 2007 A1
20070219315 Braun Sep 2007 A1
20070238824 Smak et al. Oct 2007 A1
20070238827 Brady et al. Oct 2007 A1
20070244238 Desor et al. Oct 2007 A1
20070265386 Mallo et al. Nov 2007 A1
20070270065 Bordes Nov 2007 A1
20070299180 Joecken Dec 2007 A1
20070299242 Faecke et al. Dec 2007 A1
20080014360 Kim Jan 2008 A1
20080058473 Freidzon et al. Mar 2008 A1
20080114125 Bzowej et al. May 2008 A1
20080145564 Allam et al. Jun 2008 A1
20080176968 VanSumeren et al. Jul 2008 A1
20080262144 Glockner et al. Oct 2008 A1
20080293848 Tomko et al. Nov 2008 A1
20090054546 Glockner et al. Feb 2009 A1
20090069491 Costeux et al. Mar 2009 A1
20090075046 Fox et al. Mar 2009 A1
20090111935 Fujii et al. Apr 2009 A1
20090118416 Nakamae et al. May 2009 A1
20090163635 Raynolds et al. Jun 2009 A1
20090170973 Mattiasson et al. Jul 2009 A1
20090264586 Mestach et al. Oct 2009 A1
20100029857 Soddemann et al. Feb 2010 A1
20100040668 Riman et al. Feb 2010 A1
20100041820 Eslinger et al. Feb 2010 A1
20100041821 Eslinger et al. Feb 2010 A1
20100065498 Charkoudian et al. Mar 2010 A1
20100065499 Fernandez-Lahore et al. Mar 2010 A1
20100068541 El A'mma et al. Mar 2010 A1
20100068958 Carson et al. Mar 2010 A1
20100075043 Kaimoto et al. Mar 2010 A1
20100075079 Bernal-Lara et al. Mar 2010 A1
20100090372 Ishikawa et al. Apr 2010 A1
20100093913 Jones et al. Apr 2010 A1
20100129635 Drzyzga et al. May 2010 A1
20100154146 Shah et al. Jun 2010 A1
20100160480 Tomko et al. Jun 2010 A1
20100160496 Son Jun 2010 A1
20100160551 Marlow et al. Jun 2010 A1
20100179277 Soddemann et al. Jul 2010 A1
20100197863 Bouquet et al. Aug 2010 A1
20100210784 Schmitt et al. Aug 2010 A1
20100273005 Kramer et al. Oct 2010 A1
20100273018 Scheerder et al. Oct 2010 A1
20100273924 Burckhardt Oct 2010 A1
20100273929 Kitagawa et al. Oct 2010 A1
20100280183 Kou Nov 2010 A1
20100286299 Casati et al. Nov 2010 A1
20100286325 Balk et al. Nov 2010 A1
20100297557 Cameron et al. Nov 2010 A1
20100323202 Burckhardt et al. Dec 2010 A1
20100330376 Trksak et al. Dec 2010 A1
20110009515 Casati Jan 2011 A1
20110027600 Hayes Feb 2011 A1
20110033700 Caylus Feb 2011 A1
20110064686 Zhang et al. Mar 2011 A1
20110076492 Fujita et al. Mar 2011 A1
20110079352 Shah et al. Apr 2011 A1
20110104508 Wang et al. May 2011 A1
20110118379 Tighe et al. May 2011 A1
20110124795 Van de Zande et al. May 2011 A1
20110135871 Yamamoto et al. Jun 2011 A1
20110136975 Breiner et al. Jun 2011 A1
20110144267 Schuetz et al. Jun 2011 A1
20110165398 Shoemake Jul 2011 A1
20110189253 Haddock et al. Aug 2011 A1
20110196084 Nabuurs et al. Aug 2011 A1
20110217540 Sandkuehler et al. Sep 2011 A1
20110218264 Casati et al. Sep 2011 A1
20110236587 Clark et al. Sep 2011 A1
20110311631 Baer et al. Dec 2011 A1
20120026238 Ganapathiappan et al. Feb 2012 A1
20120045485 Gan et al. Feb 2012 A1
20120071577 Pfeffer et al. Mar 2012 A1
20120077932 Pfeffer et al. Mar 2012 A1
20120101181 Munshi et al. Apr 2012 A1
20120121903 Betremieux et al. May 2012 A1
20120128743 Hawkett et al. May 2012 A1
20120140008 Ganapathiappan et al. Jun 2012 A1
20120142848 Bzowej et al. Jun 2012 A1
20120152459 Avramidis Jun 2012 A1
20120156892 Mevellec et al. Jun 2012 A1
20120157352 Musa et al. Jun 2012 A1
20120165428 Tilara et al. Jun 2012 A1
20120168384 Anzai et al. Jul 2012 A1
20120172478 Chang et al. Jul 2012 A1
20120178884 Cavallin Jul 2012 A1
20120225110 Hashino et al. Sep 2012 A1
20120237464 Ahn et al. Sep 2012 A1
20120245267 Blanchard et al. Sep 2012 A1
20120252972 Balk et al. Oct 2012 A1
20120288630 Charkoudian et al. Nov 2012 A1
20120315265 Lai et al. Dec 2012 A1
20130005887 Lellis et al. Jan 2013 A1
20130055485 Zanetta et al. Mar 2013 A1
20130059119 Campeau et al. Mar 2013 A1
20130065976 Morita et al. Mar 2013 A1
20130072405 Favero et al. Mar 2013 A1
20130122299 Rand et al. May 2013 A1
20130123436 Rand et al. May 2013 A1
20130129996 Ahn et al. May 2013 A1
20130138056 Kawamura et al. May 2013 A1
20130143039 Wilbur et al. Jun 2013 A1
20130143979 Kamiyama et al. Jun 2013 A1
20130149487 Lunsford et al. Jun 2013 A1
20130156961 Heulings et al. Jun 2013 A1
20130172504 Phelan Jul 2013 A1
20130178549 Ahn et al. Jul 2013 A1
20130178569 Guy et al. Jul 2013 A1
20130183520 Natori Jul 2013 A1
20130190468 Meier et al. Jul 2013 A1
20130203884 Blomker et al. Aug 2013 A1
20130208429 Liu Aug 2013 A1
20130231438 Kim et al. Sep 2013 A1
20130237673 Saint-Gerard et al. Sep 2013 A1
20130253107 Iyer et al. Sep 2013 A1
20130263995 Lutz et al. Oct 2013 A1
20130272943 Braga Oct 2013 A1
20130289135 Tighe et al. Oct 2013 A1
20170037263 Iyer Feb 2017 A1
Foreign Referenced Citations (4)
Number Date Country
2079926 May 1993 CA
19822790 Nov 1999 DE
9221720 Dec 1992 WO
2007012432 Feb 2007 WO
Non-Patent Literature Citations (2)
Entry
International Search Report of the European International Searching Authority from International Application No. PCT/EP2014/050197, completed Mar. 18, 2014, 4 pages.
ASTM International, Standard Specification for Liquid Applied Acrylic Coating Used in Roofing, West Conshohocken, PA, pp. 1-3, Jun. 2005.
Related Publications (1)
Number Date Country
20150361301 A1 Dec 2015 US
Provisional Applications (1)
Number Date Country
61754241 Jan 2013 US